as on January 28, 2026 at 9:30 pm IST
Day's Low
Day's High
1.16%
Downside
3.49%
Upside
52 Week's Low
52 Week's High
18.60%
Downside
186.82%
Upside
Check Veru Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$42.2M
EPS (TTM)
-1.3
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-2.97
Industry PE ratio
10.602777777777778
PEG Ratio
0EBITDA
-35.4M
Revenue (TTM)
16.9M
Profit Margin
0.00%
Return On Equity TTM
-61.92%
Track how Veru Inc P/E has moved over time to understand its valuation trends.
Veru Inc in the last 5 years
Lowest (-196.72x)
June 30, 2022
Today (-2.97x)
January 28, 2026
Industry (10.60x)
January 28, 2026
Highest (-7.41x)
June 30, 2023
Today’s Price to Earnings Ratio: -2.97x
Compare market cap, revenue, PE, and other key metrics of Veru Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $42.2M | -97.09% | -2.97 | 0.00% | |
| BUY | $47.7B | 129.26% | 1246.03 | 1.36% | |
| BUY | $122.3B | 106.13% | 33.56 | 31.35% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 52.34% | 18.28 | 32.13% |
The Veru Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Veru Inc investment value today
Current value as on today
₹55,494
Returns
Returns from Veru Inc Stock
Dollar Returns*
₹5,974 (+5.97%)
Based on 9 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Veru Inc. Average target price of $18
Get share price movements and forecasts by analysts on Veru Inc.
What analysts predicted
85.67%UPSIDE
Target Price
$18
Current Price
$2.58
Analyzed by
9 Analysts
Target
$18.00
Veru Inc target price $18, a slight upside of 85.67% compared to current price of $2.58. According to 9 analysts rating.
Search interest for Veru Inc Stock has increased by 42% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:42% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 3.95M → 6.65M (in $), with an average increase of 40.6% per quarter
Profit Spike
![]()
Netprofit is up for the last 4 quarters, -8.94M → 1.45M (in $), with an average increase of 208.5% per quarter
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 29.4% return, outperforming this stock by 124.9%
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 48.3% return, outperforming this stock by 96.9%
Price Dip
![]()
In the last 6 months, VERU stock has moved down by -49.0%
| Organisation | Veru Inc |
| Headquarters | 2916 North Miami Avenue, Miami, FL, United States, 33127 |
| Industry | Consumer Non-Durables |
| CEO | Dr. Mitchell S. Steiner F.A.C.S., M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Samuel Fisch | Executive Director of Investor Relations & Corporate Communications |
Mr. Kevin J. Gilbert CPA, J.D. | Executive Vice President of Corporate Development |
Mr. Martin Tayler | Executive Vice President of FC2 Global Operations |
Dr. Mitchell S. Steiner F.A.C.S., M.D. | Chairman, President & CEO |
Dr. Harry D. Fisch F.A.C.S., M.D. | Vice Chairman & Chief Corporate Officer |
Ms. Michele Greco CPA | CFO & Chief Administrative Officer |
Dr. Gary Bird Ph.D. | Executive Vice President of Quality & Regulatory Affairs |
Dr. K. Gary Barnette Ph.D. | Chief Scientific Officer |
Mr. Philip R. Greenberg J.D. | Executive VP & General Counsel |
Dr. Domingo Rodriguez M.D. | Executive Vice President of Global Clinical Operations |
Veru Inc share price today is $2.58 as on . Veru Inc share today touched a day high of $2.67 and a low of $2.55.
Veru Inc share touched a 52 week high of $7.4 on and a 52 week low of $2.1 on . Veru Inc stock price today i.e. is trending at $2.58,which is 65.14% down from its 52 week high and 22.86% up from its 52 week low.
Veru Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Veru Inc (VERU) shares with as little as ₹91.762 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹917.62 in Veru Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Veru Inc share’s latest price of $2.58 as on January 28, 2026 at 9:30 pm IST, you will get 3.8760 shares of Veru Inc. Learn more about
fractional shares .
Veru Inc stock has given -97.09% share price returns and 25.73% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?